Clinical Trial Update: A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial investigating tanezumab in interstitial cystitis/painful bladder syndrome was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis Interstitial
• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Cystitis, Interstitial | Phase 2 | Status: TERMINATED | Results posted: 2021-08-03